Matrine Glucose Injection
Function and Efficacy
Intraperitoneal injection of matrine into mice with cholestatic jaundice induced by 1-naphthyl isothiocyanate can reduce the levels of serum alanine aminotransferase, aspartate aminotransferase and serum conjugated bilirubin, and alleviate liver cell damage in model animals.
Ingredients
Matrine
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| MatrineIngredients |
Intraperitoneal injection of matrine into mice with cholestatic jaundice induced by 1-naphthyl isothiocyanate can reduce the levels of serum alanine aminotransferase, aspartate aminotransferase and serum conjugated bilirubin, and alleviate liver cell damage in model animals. More |
519-02-8 | 8 |
Appearance
This product is a colorless clear liquid.
Indication
Used to restore alanine aminotransferase and bilirubin to normal in patients with chronic hepatitis.
Usage and Dosage
Slow intravenous drip, once a day, 0.15g each time. Two months is a course of treatment.
Adverse Reactions
This product will not cause adverse reactions if used according to the above usage and dosage. However, if the drip speed is too fast, it will cause adverse reactions such as dizziness and nausea.
Precautions
It is contraindicated for those who are allergic to this product.
Drug Interactions
Not yet clear.
Storage
Sealed and light-proof.
Packaging Specification
250ml: matrine 0.15g and glucose 12.5g
Manufacturer
Heilongjiang Yudi Pharmaceutical Co., Ltd.
-
Founded in:
2022-08-25 -
Address:
Building 013, Peide Town, Mishan City, Jixi City, Heilongjiang Province (declaration commitment) -
Tax NO.:
91230382MABY9MBL9N -
Registered Funds:
220 million yuan -
Email: